SCHEMBL28523610

SCHEMBL28523610

NC(=O)OCc1ncc(CO)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.38
▸ NQO1 P15559 1/20 0.35
▸ ICAM1 P05362 1/20 0.33
▸ SELE P16581 1/20 0.33
▸ VCAM1 P19320 1/20 0.33
▸ ALOX15 P16050 1/20 0.31
▸ GLA P06280 1/20 0.31
▸ CYP1A2 P05177 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30
▸ PKM P14618 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30
▸ GABRP O00591 1/20 0.30
▸ GABRD O14764 1/20 0.30
▸ GABRA1 P14867 1/20 0.30
▸ GABRB1 P18505 1/20 0.30
▸ GABRG2 P18507 1/20 0.30
▸ GABRB3 P28472 1/20 0.30
▸ GABRA5 P31644 1/20 0.30
▸ GABRA3 P34903 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28446989 0.79 LMNA (0.39) LMNANQO1ALOX15GLACYP1A2
SCHEMBL28846986 0.79 CYP1A2 (0.39) LMNANQO1ALOX15GLACYP1A2
SCHEMBL28340802 0.79 LMNA (0.39) LMNANQO1ALOX15GLACYP1A2
SCHEMBL28896473 0.76 LMNA (0.40) LMNANQO1ALOX15GLACYP1A2
SCHEMBL14639041 0.76 NQO1 (0.39) LMNANQO1ALOX15CYP1A2CYP2D6
SCHEMBL28846885 0.75 LMNA (0.40) LMNANQO1PARP10
SCHEMBL28660208 0.73 CYP11B2 (0.38) LMNANQO1ICAM1SELEVCAM1
SCHEMBL1934595 0.72 KMT2A (0.44) LMNANQO1SMN1; SMN2PARP10
SCHEMBL28532598 0.72 LMNA (0.39) LMNANQO1ALOX15GLACYP1A2
SCHEMBL28993971 0.69 GABRP (0.56) SMN1; SMN2GABRPGABRDGABRA1GABRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112368289-B C26-linked rapamycin analogues as MTOR inhibitors 锐新医药公司 2024-02-20 — — CN disclosed
CN-115916194-A Methods for delaying, preventing and treating acquired resistance to RAS inhibitors 锐新医药公司 2023-04-04 — — CN disclosed
CN-112771054-A C40-, C28-and C-32-linked rapamycin analogs as mTOR inhibitors 锐新医药公司 2021-05-07 — — CN disclosed
CN-112368289-A C26-linked rapamycin analogs as MTOR inhibitors 锐新医药公司 2021-02-12 — — CN disclosed
Send feedback